Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Gastroenterology
|
October 26, 2001
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
W J Sandborn, S B Hanauer, S Katz, et al.
Alimentary Pharmacology & Therapeutics
|
November 24, 2012
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
W J Sandborn, J-F Colombel, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2016
Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy
J-F Colombel, B Jharap, W J Sandborn, et al.
Hepatology (Baltimore, Md.)
|
January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue
W J Sandborn, G M Lawson, T J Cody, et al.
The American Journal of Gastroenterology
|
May 26, 2001
Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis
A M Levy, K Yamazaki, V P Van Keulen, et al.
Journal of Clinical Pharmacology
|
January 1, 1997
A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation
B J Zins, W J Sandborn, J A McKinney, et al.
Inflammatory Bowel Diseases
|
March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
C Gasche, J Scholmerich, J Brynskov, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2018
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
S Kurnool, N H Nguyen, J Proudfoot, et al.
Clinical Pharmacology and Therapeutics
|
January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing
M V Relling, E E Gardner, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
R Khanna, G Zou, G D'Haens, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Gastroenterology
|
October 26, 2001
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
W J Sandborn, S B Hanauer, S Katz, et al.
Alimentary Pharmacology & Therapeutics
|
November 24, 2012
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
W J Sandborn, J-F Colombel, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2016
Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy
J-F Colombel, B Jharap, W J Sandborn, et al.
Hepatology (Baltimore, Md.)
|
January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue
W J Sandborn, G M Lawson, T J Cody, et al.
The American Journal of Gastroenterology
|
May 26, 2001
Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis
A M Levy, K Yamazaki, V P Van Keulen, et al.
Journal of Clinical Pharmacology
|
January 1, 1997
A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation
B J Zins, W J Sandborn, J A McKinney, et al.
Inflammatory Bowel Diseases
|
March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
C Gasche, J Scholmerich, J Brynskov, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2018
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
S Kurnool, N H Nguyen, J Proudfoot, et al.
Clinical Pharmacology and Therapeutics
|
January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing
M V Relling, E E Gardner, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
R Khanna, G Zou, G D'Haens, et al.
Page
of 19